Compare Akamai Technologies, Inc. (AKAM) vs Centene Corp (CNC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Akamai Technologies, Inc. vs Centene Corp — how do they compare? Akamai Technologies, Inc. trades at $124.34 (market cap $16.63B), while Centene Corp trades at $67.65 (market cap $32.65B). The key difference: Centene Corp is the larger of the two by market cap, and Centene Corp is trading nearer its 52-week high, Akamai Technologies, Inc. nearer its low. Which is the better fit depends on your goals.
| AKAM | CNC | |
|---|---|---|
Market Cap | $16.63B | $32.65B |
Sector | Technology | Health |
52-Week High | $161.14 | $68.34 |
52-Week Low | $70.53 | $25.21 |
Enterprise Value | $21.56B | $25.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Akamai Technologies (AKAM) trades at $114.37, up 1.06% on the day but down significantly from its 26-year high of $165.45 in May 2026. The stock faces a bearish technical signal despite recent earnings beats. Revenue growth has slowed to 5% annually, with net income margin declining from 14.47% in 2022 to 10.74% in 2025. The company continues strategic moves in cybersecurity, completing the LayerX acquisition and expanding its NVIDIA partnership for AI security.
While analyst consensus remains positive with a $170.20 price target, near-term headwinds include declining profitability, high valuation multiples, and competitive pressures. The stock's current pullback presents a potential entry point for long-term investors believing in its cybersecurity and cloud computing positioning, though execution risks and margin compression require monitoring.
Centene (CNC) trades at $66.12, down 2.56% on the day, with a bullish technical signal from moving averages despite recent weakness. The stock shows attractive valuation ratios (P/E 8.06, P/S 0.16) but faces profitability challenges with negative net income margin (-3.25%) and ROE (-26.12%). Recent earnings beats and strong analyst support (62.79% buy ratings) contrast with operational headwinds in Medicaid margins and cost pressures.
Investment outlook balances deep value against execution risks. The consensus price target of $63.29 suggests limited upside, but improving cash flow trends and AI-driven cost initiatives could support recovery. Key risks include regulatory changes, adverse selection in insurance pools, and margin sustainability amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Akamai Technologies, Inc.
Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.
Read more on AKAM →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
